ÀǾàÇ° ½ÃÀåÁ¶»çº¸°í¼­

ÀǾàÇ° ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå±Ô¸ð, »ê¾÷ºÐ¼®, ÇâÈÄ ½ÃÀ忹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.

1 - 25 (Àüü: 15,798°Ç)
¼¼°èÀÇ ¿Ã¸®°í´ºÅ¬·¹¿ÀŸÀ̵å Ä¡·áÁ¦ ½ÃÀå
Oligonucleotide Therapeutics
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 4,950 £Ü 6,727,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ À¯ÀüÀÚÇü ºÐ¼® ½ÃÀå
Genotyping
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 4,950 £Ü 6,727,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Å¬¶ó¿ìµå ±â¹Ý ½Å¾à°³¹ß Ç÷§Æû ½ÃÀå
Cloud-Based Drug Discovery Platforms
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 4,950 £Ü 6,727,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Ç÷¿ìº´ Ä¡·áÁ¦ ½ÃÀå
Hemophilia Drugs
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 4,950 £Ü 6,727,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ºÎÀΰú ¾Ï Ä¡·áÁ¦ ½ÃÀå
Gynecological Cancer Drugs
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 5,450 £Ü 7,406,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ºñ°­ ¾à¹° Àü´Þ ±â¼ú ½ÃÀå
Nasal Drug Delivery Technology
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 5,450 £Ü 7,406,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÅëÁõ ÇÑ·©¿ä¹ý ½ÃÀå
Cold Pain Therapy
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 4,950 £Ü 6,727,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÇコÄɾî ÄݵåüÀÎ ¹°·ù ½ÃÀå
Healthcare Cold Chain Logistics
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 5,450 £Ü 7,406,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Á¤½Å°ú ¹× ¾à¹° ³²¿ë º´¿ø ½ÃÀå
Psychiatric and Substance Abuse Hospitals
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 4,950 £Ü 6,727,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¹Ì»ý¹° ¹è¾ç ½ÃÀå
Microbiology Culture
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 4,950 £Ü 6,727,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÇìÆĸ° ½ÃÀå
Heparin
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 4,950 £Ü 6,727,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÀÇ·á °£º´ ½ÃÀå
Health Caregiving
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 5,450 £Ü 7,406,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Àü½Å¸¶ÃëÁ¦ ½ÃÀå
General Anesthesia Drugs
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 5,450 £Ü 7,406,000 (ºÎ°¡¼¼ º°µµ)
Top 200 ¼¼Æ÷ ¹× À¯ÀüÀÚ ½Ã¼³ À妽º : ¹ÙÀÌ¿À ÀǾàÇ° Á¦Á¶¾÷ü¿ë ±¸µ¶,µ¥ÀÌÅͺ£À̽º
Top 200 Cell and Gene Facility Index and Biomanufacturers Subscription Database
¹ßÇà ¿¬°£±¸µ¶
°¡°Ý US $ 4,450 £Ü 6,047,000 (ºÎ°¡¼¼ º°µµ)
¾Ï °ü·Ã Á¦ÈÞ ¹× ¶óÀ̼±½º °è¾à(2019-2024³â)
Oncology Collaboration and Licensing Deals 2019-2024
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 3,995 £Ü 5,429,000 (ºÎ°¡¼¼ º°µµ)
±Ù°ñ°Ý°è °ü·Ã Á¦ÈÞ ¹× ¶óÀ̼±½º °è¾à(2016-2024³â)
Musculoskeletal Collaboration and Licensing Deals 2016-2024
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 3,995 £Ü 5,429,000 (ºÎ°¡¼¼ º°µµ)
´ë»ç °ü·Ã Á¦ÈÞ ¹× ¶óÀ̼±½º °è¾à(2019-2024³â)
Metabolic Collaboration and Licensing Deals 2019-2024
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 3,995 £Ü 5,429,000 (ºÎ°¡¼¼ º°µµ)
°¨¿°Áõ °ü·Ã Á¦ÈÞ ¹× ¶óÀ̼±½º °è¾à(2019-2024³â)
Infectious Diseases Collaboration and Licensing Deals 2019-2024
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 3,995 £Ü 5,429,000 (ºÎ°¡¼¼ º°µµ)
¸é¿ª °ü·Ã Á¦ÈÞ ¹× ¶óÀ̼±½º °è¾à(2016-2024³â)
Immunology Collaboration and Licensing Deals 2016-2024
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 3,995 £Ü 5,429,000 (ºÎ°¡¼¼ º°µµ)
º´¿ø ÄÉ¾î °ü·Ã Á¦ÈÞ ¹× ¶óÀ̼±½º °è¾à(2016-2024³â)
Hospital Care Collaboration and Licensing Deals 2016-2024
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 3,995 £Ü 5,429,000 (ºÎ°¡¼¼ º°µµ)
ºÎÀΰú °ü·Ã Á¦ÈÞ ¹× ¶óÀ̼±½º °è¾à(2016-2024³â)
Gynecology Collaboration and Licensing Deals 2016-2024
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 3,995 £Ü 5,429,000 (ºÎ°¡¼¼ º°µµ)
ºñ´¢»ý½Ä±â °ü·Ã Á¦ÈÞ ¹× ¶óÀ̼±½º °è¾à(2016-2024³â)
Genitourinary Collaboration and Licensing Deals 2016-2024
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 3,995 £Ü 5,429,000 (ºÎ°¡¼¼ º°µµ)
¼ÒÈ­±â °ü·Ã Á¦ÈÞ ¹× ¶óÀ̼±½º °è¾à(2016-2024³â)
Gastrointestinal Collaboration and Licensing Deals 2016-2024
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 3,995 £Ü 5,429,000 (ºÎ°¡¼¼ º°µµ)
ÇǺΰú °ü·Ã Á¦ÈÞ ¹× ¶óÀ̼±½º °è¾à(2016-2024³â)
Dermatology Collaboration and Licensing Deals 2016-2024
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 3,995 £Ü 5,429,000 (ºÎ°¡¼¼ º°µµ)
ÁßÃ߽Űæ°è °ü·Ã Á¦ÈÞ ¹× ¶óÀ̼±½º °è¾à(2019-2024³â)
Central Nervous System Collaboration and Licensing Deals 2019-2024
¹ßÇà 2024³â 10¿ù
°¡°Ý US $ 3,995 £Ü 5,429,000 (ºÎ°¡¼¼ º°µµ)
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.